Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines by Cynthia González Muñoz, Rydell Álvarez Arzola, Adanays Calvo Pérez, Milagro de la Caridad Frometa Campanón, Patricia Hernández Casaña, Aymé Fernández-Calienes Valdés, Patricia Lorenzo-Luaces, Zaima Mazorra Herrera, Tania Crombet Ramos, Mayrel Labrada Mon

Get full text